><ref id="bib1"><mixed-citation publication-type="journal">Chen GY, Nunez G. <article-title>Sterile inflammation: sensing and reacting to damage</article-title>. <source>Nat Rev Immunol</source>
<year>2010</year>; <volume>10</volume>: <fpage>826</fpage>&#x02013;837.<pub-id pub-id-type="pmid">21088683</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">Wallach D, Kang TB, Kovalenko A. <article-title>Concepts of tissue injury and cell death in inflammation: a historical perspective</article-title>. <source>Nat Rev Immunol</source>
<year>2014</year>; <volume>14</volume>: <fpage>51</fpage>&#x02013;59.<pub-id pub-id-type="pmid">24336099</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal">Dinarello CA. <article-title>Interleukin-1 and the pathogenesis of the acute-phase response</article-title>. <source>N Engl J Med</source>
<year>1984</year>; <volume>311</volume>: <fpage>1413</fpage>&#x02013;1418.<pub-id pub-id-type="pmid">6208485</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal">Dinarello CA. <article-title>A clinical perspective of IL-1beta as the gatekeeper of inflammation</article-title>. <source>Eur J Immunol</source>
<year>2011</year>; <volume>41</volume>: <fpage>1203</fpage>&#x02013;1217.<pub-id pub-id-type="pmid">21523780</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">Dinarello CA. <article-title>Biology of interleukin 1</article-title>. <source>FASEB J</source>
<year>1988</year>; <volume>2</volume>: <fpage>108</fpage>&#x02013;115.<pub-id pub-id-type="pmid">3277884</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. <article-title>Identification of a key pathway required for the sterile inflammatory response triggered by dying cells</article-title>. <source>Nat Med</source>
<year>2007</year>; <volume>13</volume>: <fpage>851</fpage>&#x02013;856.<pub-id pub-id-type="pmid">17572686</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">Yan B, Han P, Pan L, Lu W, Xiong J, Zhang M et al. <article-title>Il-1&#x003b2; and reactive oxygen species differentially regulate neutrophil directional migration and basal random motility in a Zebrafish injury&#x02013;induced inflammation model</article-title>. <source>J Immunol</source>
<year>2014</year>; <volume>192</volume>: <fpage>5998</fpage>&#x02013;6008.<pub-id pub-id-type="pmid">24835391</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal">Garlanda C, Dinarello CA, Mantovani A. <article-title>The interleukin-1 family: back to the future</article-title>. <source>Immunity</source>
<year>2013</year>; <volume>39</volume>: <fpage>1003</fpage>&#x02013;1018.<pub-id pub-id-type="pmid">24332029</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">Hoffman HM, Wanderer AA. <article-title>Inflammasome and IL-1beta-mediated disorders</article-title>. <source>Curr Allergy Asthma Rep</source>
<year>2010</year>; <volume>10</volume>: <fpage>229</fpage>&#x02013;235.<pub-id pub-id-type="pmid">20425006</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G et al. <article-title>MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals</article-title>. <source>J Clin Invest</source>
<year>2006</year>; <volume>116</volume>: <fpage>2262</fpage>&#x02013;2271.<pub-id pub-id-type="pmid">16886064</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. <article-title>Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity</article-title>. <source>Immunity</source>
<year>2009</year>; <volume>31</volume>: <fpage>331</fpage>&#x02013;341.<pub-id pub-id-type="pmid">19682929</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal">Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. <article-title>A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis</article-title>. <source>J Exp Med</source>
<year>2006</year>; <volume>203</volume>: <fpage>1685</fpage>&#x02013;1691.<pub-id pub-id-type="pmid">16818675</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">Voronov E, Dayan M, Zinger H, Gayvoronsky L, Lin JP, Iwakura Y et al. <article-title>IL-1 beta-deficient mice are resistant to induction of experimental SLE</article-title>. <source>Eur Cytokine Netw</source>
<year>2006</year>; <volume>17</volume>: <fpage>109</fpage>&#x02013;116.<pub-id pub-id-type="pmid">16840029</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V et al. <article-title>Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs</article-title>. <source>Nature</source>
<year>1985</year>; <volume>315</volume>: <fpage>641</fpage>&#x02013;647.<pub-id pub-id-type="pmid">2989698</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">Lomedico PT, Gubler U, Hellmann CP, Dukovich M, Giri JG, Pan YC et al. <article-title>Cloning and expression of murine interleukin-1 cDNA in <italic>Escherichia coli</italic></article-title>. <source>Nature</source>
<year>1984</year>; <volume>312</volume>: <fpage>458</fpage>&#x02013;462.<pub-id pub-id-type="pmid">6209582</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolff SM et al. <article-title>Nucleotide sequence of human monocyte interleukin 1 precursor cDNA</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>1984</year>; <volume>81</volume>: <fpage>7907</fpage>&#x02013;7911.<pub-id pub-id-type="pmid">6083565</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">Taylor SL, Renshaw BR, Garka KE, Smith DE, Sims JE. <article-title>Genomic organization of the interleukin-1 locus</article-title>. <source>Genomics</source>
<year>2002</year>; <volume>79</volume>: <fpage>726</fpage>&#x02013;733.<pub-id pub-id-type="pmid">11991723</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal">Dinarello CA. <article-title>Biologic basis for interleukin-1 in disease</article-title>. <source>Blood</source>
<year>1996</year>; <volume>87</volume>: <fpage>2095</fpage>&#x02013;2147.<pub-id pub-id-type="pmid">8630372</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">Jobling SA, Auron PE, Gurka G, Webb AC, McDonald B, Rosenwasser LJ et al. <article-title>Biological activity and receptor binding of human prointerleukin-1 beta and subpeptides</article-title>. <source>J Biol Chem</source>
<year>1988</year>; <volume>263</volume>: <fpage>16372</fpage>&#x02013;16378.<pub-id pub-id-type="pmid">2972707</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">Symons JA, Eastgate JA, Duff GW. <article-title>Purification and characterization of a novel soluble receptor for interleukin 1</article-title>. <source>J Exp Med</source>
<year>1991</year>; <volume>174</volume>: <fpage>1251</fpage>&#x02013;1254.<pub-id pub-id-type="pmid">1834761</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M et al. <article-title>Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4</article-title>. <source>Science</source>
<year>1993</year>; <volume>261</volume>: <fpage>472</fpage>&#x02013;475.<pub-id pub-id-type="pmid">8332913</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">Watkins LR, Hansen MK, Nguyen KT, Lee JE, Maier SF. <article-title>Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists</article-title>. <source>Life Sci</source>
<year>1999</year>; <volume>65</volume>: <fpage>449</fpage>&#x02013;481.<pub-id pub-id-type="pmid">10462074</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">Dinarello CA, Wolff SM. <article-title>The role of interleukin-1 in disease</article-title>. <source>N Engl J Med</source>
<year>1993</year>; <volume>328</volume>: <fpage>106</fpage>&#x02013;113.<pub-id pub-id-type="pmid">8439348</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">Miller AC, Schattenberg DG, Malkinson AM, Ross D. <article-title>Decreased content of the IL1 alpha processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone</article-title>. <source>Toxicol Lett</source>
<year>1994</year>; <volume>74</volume>: <fpage>177</fpage>&#x02013;184.<pub-id pub-id-type="pmid">7940599</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal">Kavita U, Mizel SB. <article-title>Differential sensitivity of interleukin-1 alpha and -beta precursor proteins to cleavage by calpain, a calcium-dependent protease</article-title>. <source>J Biol Chem</source>
<year>1995</year>; <volume>270</volume>: <fpage>27758</fpage>&#x02013;27765.<pub-id pub-id-type="pmid">7499244</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal">Gross O, Yazdi AS, Thomas CJ, Masin M, Heinz LX, Guarda G et al. <article-title>Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1</article-title>. <source>Immunity</source>
<year>2012</year>; <volume>36</volume>: <fpage>388</fpage>&#x02013;400.<pub-id pub-id-type="pmid">22444631</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal">Martinon F, Mayor A, Tschopp J. <article-title>The inflammasomes: guardians of the body</article-title>. <source>Annu Rev Immunol</source>
<year>2009</year>; <volume>27</volume>: <fpage>229</fpage>&#x02013;265.<pub-id pub-id-type="pmid">19302040</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">Latz E, Xiao TS, Stutz A. <article-title>Activation and regulation of the inflammasomes</article-title>. <source>Nat Rev Immunol</source>
<year>2013</year>; <volume>13</volume>: <fpage>397</fpage>&#x02013;411.<pub-id pub-id-type="pmid">23702978</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">Latz E. <article-title>The inflammasomes: mechanisms of activation and function</article-title>. <source>Curr Opin Immunol</source>
<year>2010</year>; <volume>22</volume>: <fpage>28</fpage>&#x02013;33.<pub-id pub-id-type="pmid">20060699</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal">Guo H, Callaway JB, Ting JP. <article-title>Inflammasomes: mechanism of action, role in disease, and therapeutics</article-title>. <source>Nat Med</source>
<year>2015</year>; <volume>21</volume>: <fpage>677</fpage>&#x02013;687.<pub-id pub-id-type="pmid">26121197</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">Ratsimandresy RA, Dorfleutner A, Stehlik C. <article-title>An update on PYRIN domain-containing pattern recognition receptors: from immunity to pathology</article-title>. <source>Front Immunol</source>
<year>2013</year>; <volume>4</volume>: <fpage>440</fpage>.<pub-id pub-id-type="pmid">24367371</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal">Sollberger G, Strittmatter GE, Garstkiewicz M, Sand J, Beer HD. <article-title>Caspase-1: the inflammasome and beyond</article-title>. <source>Innate immunity</source>
<year>2014</year>; <volume>20</volume>: <fpage>115</fpage>&#x02013;125.<pub-id pub-id-type="pmid">23676582</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. <article-title>The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis</article-title>. <source>Nat Immunol</source>
<year>2009</year>; <volume>10</volume>: <fpage>241</fpage>&#x02013;247.<pub-id pub-id-type="pmid">19221555</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal">Lopez-Castejon G, Brough D. <article-title>Understanding the mechanism of IL-1beta secretion</article-title>. <source>Cytokine Growth Factor Rev</source>
<year>2011</year>; <volume>22</volume>: <fpage>189</fpage>&#x02013;195.<pub-id pub-id-type="pmid">22019906</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">Shirasaki Y, Yamagishi M, Suzuki N, Izawa K, Nakahara A, Mizuno J et al. <article-title>Real-time single-cell imaging of protein secretion</article-title>. <source>Sci Rep</source>
<year>2014</year>; <volume>4</volume>: <fpage>4736</fpage>.<pub-id pub-id-type="pmid">24751898</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">Liu T, Yamaguchi Y, Shirasaki Y, Shikada K, Yamagishi M, Hoshino K et al. <article-title>Single-cell imaging of caspase-1 dynamics reveals an all-or-none inflammasome signaling response</article-title>. <source>Cell Rep</source>
<year>2014</year>; <volume>8</volume>: <fpage>974</fpage>&#x02013;982.<pub-id pub-id-type="pmid">25127135</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">Harris J, Hartman M, Roche C, Zeng SG, O'Shea A, Sharp FA et al. <article-title>Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation</article-title>. <source>J Biol Chem</source>
<year>2011</year>; <volume>286</volume>: <fpage>9587</fpage>&#x02013;9597.<pub-id pub-id-type="pmid">21228274</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal">Zhang M, Kenny S, Ge L, Xu K, Schekman R. <article-title>Translocation of interleukin-1beta into a vesicle intermediate in autophagy-mediated secretion</article-title>. <source>Elife</source>
<year>2015</year>; <volume>4</volume>: <fpage>e11205</fpage>.<pub-id pub-id-type="pmid">26523392</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">Jiang S, Dupont N, Castillo EF, Deretic V. <article-title>Secretory versus degradative autophagy: unconventional secretion of inflammatory mediators</article-title>. <source>J Innate Immun</source>
<year>2013</year>; <volume>5</volume>: <fpage>471</fpage>&#x02013;479.<pub-id pub-id-type="pmid">23445716</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">Piccioli P, Rubartelli A. <article-title>The secretion of IL-1beta and options for release</article-title>. <source>Semin Immunol</source>
<year>2013</year>; <volume>25</volume>: <fpage>425</fpage>&#x02013;429.<pub-id pub-id-type="pmid">24201029</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal">Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H et al. <article-title>Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>1999</year>; <volume>96</volume>: <fpage>6261</fpage>&#x02013;6266.<pub-id pub-id-type="pmid">10339575</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal">Sugawara S, Uehara A, Nochi T, Yamaguchi T, Ueda H, Sugiyama A et al. <article-title>Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells</article-title>. <source>J Immunol</source>
<year>2001</year>; <volume>167</volume>: <fpage>6568</fpage>&#x02013;6575.<pub-id pub-id-type="pmid">11714826</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal">Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. <article-title>IL-1beta processing in host defense: beyond the inflammasomes</article-title>. <source>PLoS Pathog</source>
<year>2010</year>; <volume>6</volume>: <fpage>e1000661</fpage>.<pub-id pub-id-type="pmid">20195505</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal">Dinarello CA, Bendtzen K, Wolff SM. <article-title>Studies on the active site of human leukocytic pyrogen</article-title>. <source>Inflammation</source>
<year>1982</year>; <volume>6</volume>: <fpage>63</fpage>&#x02013;78.<pub-id pub-id-type="pmid">7085045</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal">Schonbeck U, Mach F, Libby P. <article-title>Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing</article-title>. <source>J Immunol</source>
<year>1998</year>; <volume>161</volume>: <fpage>3340</fpage>&#x02013;3346.<pub-id pub-id-type="pmid">9759850</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal">Herzog C, Haun RS, Kaushal V, Mayeux PR, Shah SV, Kaushal GP et al. <article-title>and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2009</year>; <volume>379</volume>: <fpage>904</fpage>&#x02013;908.<pub-id pub-id-type="pmid">19135030</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal">Cullen SP, Kearney CJ, Clancy DM, Martin SJ. <article-title>Diverse activators of the NLRP3 inflammasome promote IL-1beta secretion by triggering necrosis</article-title>. <source>Cell Rep</source>
<year>2015</year>; <volume>11</volume>: <fpage>1535</fpage>&#x02013;1548.<pub-id pub-id-type="pmid">26027935</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal">Mosley B, Urdal DL, Prickett KS, Larsen A, Cosman D, Conlon PJ et al. <article-title>The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor</article-title>. <source>J Biol Chem</source>
<year>1987</year>; <volume>262</volume>: <fpage>2941</fpage>&#x02013;2944.<pub-id pub-id-type="pmid">2950091</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal">Hazuda D, Webb RL, Simon P, Young P. <article-title>Purification and characterization of human recombinant precursor interleukin 1 beta</article-title>. <source>J Biol Chem</source>
<year>1989</year>; <volume>264</volume>: <fpage>1689</fpage>&#x02013;1693.<pub-id pub-id-type="pmid">2643602</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal">Wang D, Zhang S, Li L, Liu X, Mei K, Wang X. <article-title>Structural insights into the assembly and activation of IL-1beta with its receptors</article-title>. <source>Nat Immunol</source>
<year>2010</year>; <volume>11</volume>: <fpage>905</fpage>&#x02013;911.<pub-id pub-id-type="pmid">20802483</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal">Huang J, Gao X, Li S, Cao Z. <article-title>Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>1997</year>; <volume>94</volume>: <fpage>12829</fpage>&#x02013;12832.<pub-id pub-id-type="pmid">9371760</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal">Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G. <article-title>Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex</article-title>. <source>J Biol Chem</source>
<year>1995</year>; <volume>270</volume>: <fpage>13757</fpage>&#x02013;13765.<pub-id pub-id-type="pmid">7775431</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal">Loiarro M, Volpe E, Ruggiero V, Gallo G, Furlan R, Maiorino C et al. <article-title>Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells</article-title>. <source>J Biol Chem</source>
<year>2013</year>; <volume>288</volume>: <fpage>30210</fpage>&#x02013;30222.<pub-id pub-id-type="pmid">24019529</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal">Radons J, Dove S, Neumann D, Altmann R, Botzki A, Martin MU et al. <article-title>The interleukin 1 (IL-1) receptor accessory protein Toll/IL-1 receptor domain: analysis of putative interaction sites <italic>in vitro</italic> mutagenesis and molecular modeling</article-title>. <source>J Biol Chem</source>
<year>2003</year>; <volume>278</volume>: <fpage>49145</fpage>&#x02013;49153.<pub-id pub-id-type="pmid">13679373</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal">Yamin TT, Miller DK. <article-title>The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation</article-title>. <source>J Biol Chem</source>
<year>1997</year>; <volume>272</volume>: <fpage>21540</fpage>&#x02013;21547.<pub-id pub-id-type="pmid">9261174</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal">Cao Z, Henzel WJ, Gao X. <article-title>IRAK: a kinase associated with the interleukin-1 receptor</article-title>. <source>Science</source>
<year>1996</year>; <volume>271</volume>: <fpage>1128</fpage>&#x02013;1131.<pub-id pub-id-type="pmid">8599092</pub-id></mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal">Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, Kumagai Y et al. <article-title>Sequential control of toll-like receptor-dependent responses by IRAK1 and IRAK2</article-title>. <source>Nat Immunol</source>
<year>2008</year>; <volume>9</volume>: <fpage>684</fpage>&#x02013;691.<pub-id pub-id-type="pmid">18438411</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal">Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. <article-title>TRAF6 is a signal transducer for interleukin-1</article-title>. <source>Nature</source>
<year>1996</year>; <volume>383</volume>: <fpage>443</fpage>&#x02013;446.<pub-id pub-id-type="pmid">8837778</pub-id></mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal">Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K et al. <article-title>TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway</article-title>. <source>Mol Cell</source>
<year>2000</year>; <volume>5</volume>: <fpage>649</fpage>&#x02013;658.<pub-id pub-id-type="pmid">10882101</pub-id></mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal">Miller LS, O'Connell RM, Gutierrez MA, Pietras EM, Shahangian A, Gross CE et al. <article-title>MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against <italic>Staphylococcus aureus</italic></article-title>. <source>Immunity</source>
<year>2006</year>; <volume>24</volume>: <fpage>79</fpage>&#x02013;91.<pub-id pub-id-type="pmid">16413925</pub-id></mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal">Miller LS, Cho JS. <article-title>Immunity against <italic>Staphylococcus aureus</italic> cutaneous infections</article-title>. <source>Nat Rev Immunol</source>
<year>2011</year>; <volume>11</volume>: <fpage>505</fpage>&#x02013;518.<pub-id pub-id-type="pmid">21720387</pub-id></mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal">Schultz MJ, Rijneveld AW, Florquin S, Edwards CK, Dinarello CA, van der Poll T. <article-title>Role of interleukin-1 in the pulmonary immune response during <italic>Pseudomonas aeruginosa</italic> pneumonia</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source>
<year>2002</year>; <volume>282</volume>: <fpage>L285</fpage>&#x02013;L290.<pub-id pub-id-type="pmid">11792633</pub-id></mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal">Joosten LA, Van De Veerdonk FL, Vonk AG, Boerman OC, Keuter M, Fantuzzi G et al. <article-title>Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1alpha, IL-1beta or IL-1 receptor type I</article-title>. <source>APMIS</source>
<year>2010</year>; <volume>118</volume>: <fpage>1000</fpage>&#x02013;1007.<pub-id pub-id-type="pmid">21091783</pub-id></mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal">Hultgren OH, Svensson L, Tarkowski A. <article-title>Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during <italic>Staphylococcus aureus</italic> infection</article-title>. <source>J Immunol</source>
<year>2002</year>; <volume>168</volume>: <fpage>5207</fpage>&#x02013;5212.<pub-id pub-id-type="pmid">11994477</pub-id></mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal">Sansonetti PJ, Phalipon A, Arondel J, Thirumalai K, Banerjee S, Akira S et al. <article-title>Caspase-1 activation of IL-1&#x003b2; and IL-18 are essential for <italic>Shigella flexneri</italic>&#x02013;induced inflammation</article-title>. <source>Immunity</source>
<year>2000</year>; <volume>12</volume>: <fpage>581</fpage>&#x02013;590.<pub-id pub-id-type="pmid">10843390</pub-id></mixed-citation></ref><ref id="bib66"><mixed-citation publication-type="journal">Barry KC, Fontana MF, Portman JL, Dugan AS, Vance RE. <article-title>IL-1alpha signaling initiates the inflammatory response to virulent <italic>Legionella pneumophila in vivo</italic></article-title>. <source>J Immunol</source>
<year>2013</year>; <volume>190</volume>: <fpage>6329</fpage>&#x02013;6339.<pub-id pub-id-type="pmid">23686480</pub-id></mixed-citation></ref><ref id="bib67"><mixed-citation publication-type="journal">Mariathasan S, Weiss DS, Dixit VM, Monack DM. <article-title>Innate immunity against <italic>Francisella tularensis</italic> is dependent on the ASC/caspase-1 axis</article-title>. <source>J Exp Med</source>
<year>2005</year>; <volume>202</volume>: <fpage>1043</fpage>&#x02013;1049.<pub-id pub-id-type="pmid">16230474</pub-id></mixed-citation></ref><ref id="bib68"><mixed-citation publication-type="journal">Verdrengh M, Thomas JA, Hultgren OH. <article-title>IL-1 receptor-associated kinase 1 mediates protection against <italic>Staphylococcus aureus</italic> infection</article-title>. <source>Microbes infect</source>
<year>2004</year>; <volume>6</volume>: <fpage>1268</fpage>&#x02013;1272.<pub-id pub-id-type="pmid">15555532</pub-id></mixed-citation></ref><ref id="bib69"><mixed-citation publication-type="journal">Moayeri M, Crown D, Newman ZL, Okugawa S, Eckhaus M, Cataisson C et al. <article-title>Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment</article-title>. <source>PLoS Pathog</source>
<year>2010</year>; <volume>6</volume>: <fpage>e1001222</fpage>.<pub-id pub-id-type="pmid">21170303</pub-id></mixed-citation></ref><ref id="bib70"><mixed-citation publication-type="journal">Zhao Y, Shao F. <article-title>Diverse mechanisms for inflammasome sensing of cytosolic bacteria and bacterial virulence</article-title>. <source>Curr Opin Microbiol</source>
<year>2015</year>; <volume>29</volume>: <fpage>37</fpage>&#x02013;42.<pub-id pub-id-type="pmid">26562791</pub-id></mixed-citation></ref><ref id="bib71"><mixed-citation publication-type="journal">van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. <article-title>Inflammasome activation and IL-1beta and IL-18 processing during infection</article-title>. <source>Trends Immunol</source>
<year>2011</year>; <volume>32</volume>: <fpage>110</fpage>&#x02013;116.<pub-id pub-id-type="pmid">21333600</pub-id></mixed-citation></ref><ref id="bib72"><mixed-citation publication-type="journal">Vladimer GI, Marty-Roix R, Ghosh S, Weng D, Lien E. <article-title>Inflammasomes and host defenses against bacterial infections</article-title>. <source>Curr Opin Microbiol</source>
<year>2013</year>; <volume>16</volume>: <fpage>23</fpage>&#x02013;31.<pub-id pub-id-type="pmid">23318142</pub-id></mixed-citation></ref><ref id="bib73"><mixed-citation publication-type="journal">Yamada H, Mizumo S, Horai R, Iwakura Y, Sugawara I. <article-title>Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice</article-title>. <source>Lab Invest</source>
<year>2000</year>; <volume>80</volume>: <fpage>759</fpage>&#x02013;767.<pub-id pub-id-type="pmid">10830786</pub-id></mixed-citation></ref><ref id="bib74"><mixed-citation publication-type="journal">Sugawara I, Yamada H, Hua S, Mizuno S. <article-title>Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection</article-title>. <source>Microbiol Immunol</source>
<year>2001</year>; <volume>45</volume>: <fpage>743</fpage>&#x02013;750.<pub-id pub-id-type="pmid">11791667</pub-id></mixed-citation></ref><ref id="bib75"><mixed-citation publication-type="journal">Juffermans NP, Florquin S, Camoglio L, Verbon A, Kolk AH, Speelman P et al. <article-title>Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis</article-title>. <source>J Infect Dis</source>
<year>2000</year>; <volume>182</volume>: <fpage>902</fpage>&#x02013;908.<pub-id pub-id-type="pmid">10950787</pub-id></mixed-citation></ref><ref id="bib76"><mixed-citation publication-type="journal">Novikov A, Cardone M, Thompson R, Shenderov K, Kirschman KD, Mayer-Barber KD et al. <article-title><italic>Mycobacterium tuberculosis</italic> triggers host type I IFN signaling to regulate IL-1beta production in human macrophages</article-title>. <source>J Immunol</source>
<year>2011</year>; <volume>187</volume>: <fpage>2540</fpage>&#x02013;2547.<pub-id pub-id-type="pmid">21784976</pub-id></mixed-citation></ref><ref id="bib77"><mixed-citation publication-type="journal">Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, Cheever A et al. <article-title>Caspase-1 independent IL-1beta production is critical for host resistance to <italic>mycobacterium tuberculosis</italic> and does not require TLR signaling <italic>in vivo</italic></article-title>. <source>J Immunol</source>
<year>2010</year>; <volume>184</volume>: <fpage>3326</fpage>&#x02013;3330.<pub-id pub-id-type="pmid">20200276</pub-id></mixed-citation></ref><ref id="bib78"><mixed-citation publication-type="journal">Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J et al. <article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title>. <source>Nature</source>
<year>2014</year>; <volume>511</volume>: <fpage>99</fpage>&#x02013;103.<pub-id pub-id-type="pmid">24990750</pub-id></mixed-citation></ref><ref id="bib79"><mixed-citation publication-type="journal">Mayer-Barber KD, Andrade BB, Barber DL, Hieny S, Feng CG, Caspar P et al. <article-title>Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunity</source>
<year>2011</year>; <volume>35</volume>: <fpage>1023</fpage>&#x02013;1034.<pub-id pub-id-type="pmid">22195750</pub-id></mixed-citation></ref><ref id="bib80"><mixed-citation publication-type="journal">Di Paolo NC, Shafiani S, Day T, Papayannoupoulou T, Russell DW, Iwakura Y et al. <article-title>Interdependence between interleukin-1 and tumor necrosis factor regulates TNF-dependent control of <italic>Mycobacterium tuberculosis</italic> Infection</article-title>. <source>Immunity</source>
<year>2015</year>; <volume>43</volume>: <fpage>1125</fpage>&#x02013;1136.<pub-id pub-id-type="pmid">26682985</pub-id></mixed-citation></ref><ref id="bib81"><mixed-citation publication-type="journal">Fremond CM, Togbe D, Doz E, Rose S, Vasseur V, Maillet I et al. <article-title>IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source>
<year>2007</year>; <volume>179</volume>: <fpage>1178</fpage>&#x02013;1189.<pub-id pub-id-type="pmid">17617611</pub-id></mixed-citation></ref><ref id="bib82"><mixed-citation publication-type="journal">Mishra BB, Rathinam VA, Martens GW, Martinot AJ, Kornfeld H, Fitzgerald KA et al. <article-title>Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta</article-title>. <source>Nat Immunol</source>
<year>2013</year>; <volume>14</volume>: <fpage>52</fpage>&#x02013;60.<pub-id pub-id-type="pmid">23160153</pub-id></mixed-citation></ref><ref id="bib83"><mixed-citation publication-type="journal">Netea MG, van de Veerdonk FL, van der Meer JW, Dinarello CA, Joosten LA. <article-title>Inflammasome-independent regulation of IL-1-family cytokines</article-title>. <source>Annu Rev Immunol</source>
<year>2015</year>; <volume>33</volume>: <fpage>49</fpage>&#x02013;77.<pub-id pub-id-type="pmid">25493334</pub-id></mixed-citation></ref><ref id="bib84"><mixed-citation publication-type="journal">McElvania Tekippe E, Allen IC, Hulseberg PD, Sullivan JT, McCann JR, Sandor M et al. <article-title>Granuloma formation and host defense in chronic <italic>Mycobacterium tuberculosis</italic> infection requires PYCARD/ASC but not NLRP3 or caspase-1</article-title>. <source>PLoS One</source>
<year>2010</year>; <volume>5</volume>: <fpage>e12320</fpage>.<pub-id pub-id-type="pmid">20808838</pub-id></mixed-citation></ref><ref id="bib85"><mixed-citation publication-type="journal">Dorhoi A, Nouailles G, Jorg S, Hagens K, Heinemann E, Pradl L et al. <article-title>Activation of the NLRP3 inflammasome by <italic>Mycobacterium tuberculosis</italic> is uncoupled from susceptibility to active tuberculosis</article-title>. <source>Eur J Immunol</source>
<year>2012</year>; <volume>42</volume>: <fpage>374</fpage>&#x02013;384.<pub-id pub-id-type="pmid">22101787</pub-id></mixed-citation></ref><ref id="bib86"><mixed-citation publication-type="journal">Walter K, Holscher C, Tschopp J, Ehlers S. <article-title>NALP3 is not necessary for early protection against experimental tuberculosis</article-title>. <source>Immunobiology</source>
<year>2010</year>; <volume>215</volume>: <fpage>804</fpage>&#x02013;811.<pub-id pub-id-type="pmid">20579764</pub-id></mixed-citation></ref><ref id="bib87"><mixed-citation publication-type="journal">Prantner D, Darville T, Sikes JD, Andrews CW Jr, Brade H, Rank RG et al. <article-title>Critical role for interleukin-1beta (IL-1beta) during <italic>Chlamydia muridarum</italic> genital infection and bacterial replication-independent secretion of IL-1beta in mouse macrophages</article-title>. <source>Infect Immun</source>
<year>2009</year>; <volume>77</volume>: <fpage>5334</fpage>&#x02013;5346.<pub-id pub-id-type="pmid">19805535</pub-id></mixed-citation></ref><ref id="bib88"><mixed-citation publication-type="journal">Cheng W, Shivshankar P, Zhong Y, Chen D, Li Z, Zhong G. <article-title>Intracellular interleukin-1alpha mediates interleukin-8 production induced by <italic>Chlamydia trachomatis</italic> infection via a mechanism independent of type I interleukin-1 receptor</article-title>. <source>Infect immun</source>
<year>2008</year>; <volume>76</volume>: <fpage>942</fpage>&#x02013;951.<pub-id pub-id-type="pmid">18086816</pub-id></mixed-citation></ref><ref id="bib89"><mixed-citation publication-type="journal">Schmitz N, Kurrer M, Bachmann MF, Kopf M. <article-title>Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection</article-title>. <source>J Virol</source>
<year>2005</year>; <volume>79</volume>: <fpage>6441</fpage>&#x02013;6448.<pub-id pub-id-type="pmid">15858027</pub-id></mixed-citation></ref><ref id="bib90"><mixed-citation publication-type="journal">Liu Y, Li S, Zhang G, Nie G, Meng Z, Mao D et al. <article-title>Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus</article-title>. <source>BMC Immunol</source>
<year>2013</year>; <volume>14</volume>: <fpage>37</fpage>.<pub-id pub-id-type="pmid">23927441</pub-id></mixed-citation></ref><ref id="bib91"><mixed-citation publication-type="journal">Kim KS, Jung H, Shin IK, Choi BR, Kim DH. <article-title>Induction of interleukin-1 beta (IL-1beta) is a critical component of lung inflammation during influenza A (H1N1) virus infection</article-title>. <source>J Med Virol</source>
<year>2015</year>; <volume>87</volume>: <fpage>1104</fpage>&#x02013;1112.<pub-id pub-id-type="pmid">25802122</pub-id></mixed-citation></ref><ref id="bib92"><mixed-citation publication-type="journal">Poli G, Kinter AL, Fauci AS. <article-title>Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>1994</year>; <volume>91</volume>: <fpage>108</fpage>&#x02013;112.<pub-id pub-id-type="pmid">7506410</pub-id></mixed-citation></ref><ref id="bib93"><mixed-citation publication-type="journal">Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR. <article-title>Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1</article-title>. <source>Mol Med</source>
<year>1995</year>; <volume>1</volume>: <fpage>667</fpage>&#x02013;677.<pub-id pub-id-type="pmid">8529133</pub-id></mixed-citation></ref><ref id="bib94"><mixed-citation publication-type="journal">Witkin SS, Linhares IM, Gerber S, Caetano ME, Segurado AC. <article-title>Interleukin-1 receptor antagonist gene polymorphism and circulating levels of human immunodeficiency virus type 1 RNA in Brazilian women</article-title>. <source>J Virol</source>
<year>2001</year>; <volume>75</volume>: <fpage>6242</fpage>&#x02013;6244.<pub-id pub-id-type="pmid">11390630</pub-id></mixed-citation></ref><ref id="bib95"><mixed-citation publication-type="journal">Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O et al. <article-title>Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection</article-title>. <source>Nature</source>
<year>2014</year>; <volume>505</volume>: <fpage>509</fpage>&#x02013;514.<pub-id pub-id-type="pmid">24356306</pub-id></mixed-citation></ref><ref id="bib96"><mixed-citation publication-type="journal">Deeks SG. <article-title>HIV infection, inflammation, immunosenescence, and aging</article-title>. <source>Annu Rev Med</source>
<year>2011</year>; <volume>62</volume>: <fpage>141</fpage>&#x02013;155.<pub-id pub-id-type="pmid">21090961</pub-id></mixed-citation></ref><ref id="bib97"><mixed-citation publication-type="journal">Romani L. <article-title>Immunity to fungal infections</article-title>. <source>Nat Rev Immunol</source>
<year>2004</year>; <volume>4</volume>: <fpage>1</fpage>&#x02013;23.<pub-id pub-id-type="pmid">14661066</pub-id></mixed-citation></ref><ref id="bib98"><mixed-citation publication-type="journal">Vonk AG, Netea MG, van Krieken JH, Iwakura Y, van der Meer JW, Kullberg BJ. <article-title>Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis</article-title>. <source>J Infect Dis</source>
<year>2006</year>; <volume>193</volume>: <fpage>1419</fpage>&#x02013;1426.<pub-id pub-id-type="pmid">16619190</pub-id></mixed-citation></ref><ref id="bib99"><mixed-citation publication-type="journal">Caffrey AK, Lehmann MM, Zickovich JM, Espinosa V, Shepardson KM, Watschke CP et al. <article-title>IL-1alpha signaling is critical for leukocyte recruitment after pulmonary <italic>Aspergillus fumigatus</italic> challenge</article-title>. <source>PLoS Pathog</source>
<year>2015</year>; <volume>11</volume>: <fpage>e1004625</fpage>.<pub-id pub-id-type="pmid">25629406</pub-id></mixed-citation></ref><ref id="bib100"><mixed-citation publication-type="journal">Isaacs A, Lindenmann J. <article-title>Virus interference. I. The interferon</article-title>. <source>Proc R Soc Lond B Biol Sci</source>
<year>1957</year>; <volume>147</volume>: <fpage>258</fpage>&#x02013;267.<pub-id pub-id-type="pmid">13465720</pub-id></mixed-citation></ref><ref id="bib101"><mixed-citation publication-type="journal">Pestka S, Krause CD, Walter MR. <article-title>Interferons, interferon-like cytokines, and their receptors</article-title>. <source>Immunol Rev</source>
<year>2004</year>; <volume>202</volume>: <fpage>8</fpage>&#x02013;32.<pub-id pub-id-type="pmid">15546383</pub-id></mixed-citation></ref><ref id="bib102"><mixed-citation publication-type="journal">Gonzalez-Navajas JM, Lee J, David M, Raz E. <article-title>Immunomodulatory functions of type I interferons</article-title>. <source>Nat Rev Immunol</source>
<year>2012</year>; <volume>12</volume>: <fpage>125</fpage>&#x02013;135.<pub-id pub-id-type="pmid">22222875</pub-id></mixed-citation></ref><ref id="bib103"><mixed-citation publication-type="journal">Kawai T, Akira S. <article-title>The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors</article-title>. <source>Nat Immunol</source>
<year>2010</year>; <volume>11</volume>: <fpage>373</fpage>&#x02013;384.<pub-id pub-id-type="pmid">20404851</pub-id></mixed-citation></ref><ref id="bib104"><mixed-citation publication-type="journal">Watanabe T, Asano N, Fichtner-Feigl S, Gorelick PL, Tsuji Y, Matsumoto Y et al. <article-title>NOD1 contributes to mouse host defense against <italic>Helicobacter pylori</italic> via induction of type I IFN and activation of the ISGF3 signaling pathway</article-title>. <source>J Clin Invest</source>
<year>2010</year>; <volume>120</volume>: <fpage>1645</fpage>&#x02013;1662.<pub-id pub-id-type="pmid">20389019</pub-id></mixed-citation></ref><ref id="bib105"><mixed-citation publication-type="journal">Pandey AK, Yang Y, Jiang Z, Fortune SM, Coulombe F, Behr MA et al. <article-title>NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PLoS Pathog</source>
<year>2009</year>; <volume>5</volume>: <fpage>e1000500</fpage>.<pub-id pub-id-type="pmid">19578435</pub-id></mixed-citation></ref><ref id="bib106"><mixed-citation publication-type="journal">Chiu YH, Macmillan JB, Chen ZJ. <article-title>RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway</article-title>. <source>Cell</source>
<year>2009</year>; <volume>138</volume>: <fpage>576</fpage>&#x02013;591.<pub-id pub-id-type="pmid">19631370</pub-id></mixed-citation></ref><ref id="bib107"><mixed-citation publication-type="journal">Parvatiyar K, Zhang Z, Teles RM, Ouyang S, Jiang Y, Iyer SS et al. <article-title>The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response</article-title>. <source>Nat Immunol</source>
<year>2012</year>; <volume>13</volume>: <fpage>1155</fpage>&#x02013;1161.<pub-id pub-id-type="pmid">23142775</pub-id></mixed-citation></ref><ref id="bib108"><mixed-citation publication-type="journal">Thompson MR, Sharma S, Atianand M, Jensen SB, Carpenter S, Knipe DM et al. <article-title>Interferon gamma-inducible protein (IFI) 16 transcriptionally regulates type i interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses</article-title>. <source>J Biol Chem</source>
<year>2014</year>; <volume>289</volume>: <fpage>23568</fpage>&#x02013;23581.<pub-id pub-id-type="pmid">25002588</pub-id></mixed-citation></ref><ref id="bib109"><mixed-citation publication-type="journal">Sun L, Wu J, Du F, Chen X, Chen ZJ. <article-title>Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway</article-title>. <source>Science</source>
<year>2013</year>; <volume>339</volume>: <fpage>786</fpage>&#x02013;791.<pub-id pub-id-type="pmid">23258413</pub-id></mixed-citation></ref><ref id="bib110"><mixed-citation publication-type="journal">Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C et al. <article-title>Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology</article-title>. <source>Nat Immunol</source>
<year>2001</year>; <volume>2</volume>: <fpage>1144</fpage>&#x02013;1150.<pub-id pub-id-type="pmid">11713464</pub-id></mixed-citation></ref><ref id="bib111"><mixed-citation publication-type="journal">Colonna M, Krug A, Cella M. <article-title>Interferon-producing cells: on the front line in immune responses against pathogens</article-title>. <source>Curr Opin Immunol</source>
<year>2002</year>; <volume>14</volume>: <fpage>373</fpage>&#x02013;379.<pub-id pub-id-type="pmid">11973137</pub-id></mixed-citation></ref><ref id="bib112"><mixed-citation publication-type="journal">Trinchieri G. <article-title>[Physiology of the immune system]</article-title>. <source>Minerva Anestesiol</source>
<year>1978</year>; <volume>44</volume>: <fpage>673</fpage>&#x02013;678.<pub-id pub-id-type="pmid">312474</pub-id></mixed-citation></ref><ref id="bib113"><mixed-citation publication-type="journal">Iwasaki A, Medzhitov R. <article-title>Toll-like receptor control of the adaptive immune responses</article-title>. <source>Nat Immunol</source>
<year>2004</year>; <volume>5</volume>: <fpage>987</fpage>&#x02013;995.<pub-id pub-id-type="pmid">15454922</pub-id></mixed-citation></ref><ref id="bib114"><mixed-citation publication-type="journal">Dunn GP, Koebel CM, Schreiber RD. <article-title>Interferons, immunity and cancer immunoediting</article-title>. <source>Nat Rev Immunol</source>
<year>2006</year>; <volume>6</volume>: <fpage>836</fpage>&#x02013;848.<pub-id pub-id-type="pmid">17063185</pub-id></mixed-citation></ref><ref id="bib115"><mixed-citation publication-type="journal">Ivashkiv LB, Donlin LT. <article-title>Regulation of type I interferon responses</article-title>. <source>Nat Rev Immunol</source>
<year>2014</year>; <volume>14</volume>: <fpage>36</fpage>&#x02013;49.<pub-id pub-id-type="pmid">24362405</pub-id></mixed-citation></ref><ref id="bib116"><mixed-citation publication-type="journal">Platanias LC. <article-title>Mechanisms of type-I-and type-II-interferon-mediated signalling</article-title>. <source>Nat Rev Immunol</source>
<year>2005</year>; <volume>5</volume>: <fpage>375</fpage>&#x02013;386.<pub-id pub-id-type="pmid">15864272</pub-id></mixed-citation></ref><ref id="bib117"><mixed-citation publication-type="journal">Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A et al. <article-title>Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection</article-title>. <source>Science</source>
<year>2002</year>; <volume>297</volume>: <fpage>2063</fpage>&#x02013;2066.<pub-id pub-id-type="pmid">12242445</pub-id></mixed-citation></ref><ref id="bib118"><mixed-citation publication-type="journal">Ivashkiv LB, Donlin LT. <article-title>Regulation of type I interferon responses</article-title>. <source>Nat Rev Immunol</source>
<year>2014</year>; <volume>14</volume>: <fpage>36</fpage>&#x02013;49.<pub-id pub-id-type="pmid">24362405</pub-id></mixed-citation></ref><ref id="bib119"><mixed-citation publication-type="journal">Rauch I, Muller M, Decker T. <article-title>The regulation of inflammation by interferons and their STATs</article-title>. <source>JAKSTAT</source>
<year>2013</year>; <volume>2</volume>: <fpage>e23820</fpage>.<pub-id pub-id-type="pmid">24058799</pub-id></mixed-citation></ref><ref id="bib120"><mixed-citation publication-type="journal">Yan N, Chen ZJ. <article-title>Intrinsic antiviral immunity</article-title>. <source>Nat Immunol</source>
<year>2012</year>; <volume>13</volume>: <fpage>214</fpage>&#x02013;222.<pub-id pub-id-type="pmid">22344284</pub-id></mixed-citation></ref><ref id="bib121"><mixed-citation publication-type="journal">Versteeg GA, Garcia-Sastre A. <article-title>Viral tricks to grid-lock the type I interferon system</article-title>. <source>Curr Opin Microbiol</source>
<year>2010</year>; <volume>13</volume>: <fpage>508</fpage>&#x02013;516.<pub-id pub-id-type="pmid">20538505</pub-id></mixed-citation></ref><ref id="bib122"><mixed-citation publication-type="journal">McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. <article-title>Type I interferons in infectious disease</article-title>. <source>Nat Rev Immunol</source>
<year>2015</year>; <volume>15</volume>: <fpage>87</fpage>&#x02013;103.<pub-id pub-id-type="pmid">25614319</pub-id></mixed-citation></ref><ref id="bib123"><mixed-citation publication-type="journal">Durbin JE, Fernandez-Sesma A, Lee CK, Rao TD, Frey AB, Moran TM et al. <article-title>Type I IFN modulates innate and specific antiviral immunity</article-title>. <source>J Immunol</source>
<year>2000</year>; <volume>164</volume>: <fpage>4220</fpage>&#x02013;4228.<pub-id pub-id-type="pmid">10754318</pub-id></mixed-citation></ref><ref id="bib124"><mixed-citation publication-type="journal">Bogdan C. <article-title>The function of type I interferons in antimicrobial immunity</article-title>. <source>Curr Opin Immunol</source>
<year>2000</year>; <volume>12</volume>: <fpage>419</fpage>&#x02013;424.<pub-id pub-id-type="pmid">10899033</pub-id></mixed-citation></ref><ref id="bib125"><mixed-citation publication-type="journal">Majer O, Bourgeois C, Zwolanek F, Lassnig C, Kerjaschki D, Mack M et al. <article-title>Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections</article-title>. <source>PLoS Pathog</source>
<year>2012</year>; <volume>8</volume>: <fpage>e1002811</fpage>.<pub-id pub-id-type="pmid">22911155</pub-id></mixed-citation></ref><ref id="bib126"><mixed-citation publication-type="journal">Biondo C, Midiri A, Gambuzza M, Gerace E, Falduto M, Galbo R et al. <article-title>IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental <italic>cryptococcosis</italic></article-title>. <source>J Immunol</source>
<year>2008</year>; <volume>181</volume>: <fpage>566</fpage>&#x02013;573.<pub-id pub-id-type="pmid">18566423</pub-id></mixed-citation></ref><ref id="bib127"><mixed-citation publication-type="journal">Sionov E, Mayer-Barber KD, Chang YC, Kauffman KD, Eckhaus MA, Salazar AM et al. <article-title>Type I IFN induction via poly-ICLC protects mice against <italic>cryptococcosis</italic></article-title>. <source>PLoS Pathog</source>
<year>2015</year>; <volume>11</volume>: <fpage>e1005040</fpage>.<pub-id pub-id-type="pmid">26252005</pub-id></mixed-citation></ref><ref id="bib128"><mixed-citation publication-type="journal">Tandon RN, Feuillette AR, Mahouy G, Badillet G, Friedman RM, Maheshwari RK. <article-title>Interferon protects mice against an extracellular infection of <italic>Aspergillus fumigatus</italic></article-title>. <source>Ann N Y Acad Sci</source>
<year>1988</year>; <volume>544</volume>: <fpage>409</fpage>&#x02013;411.<pub-id pub-id-type="pmid">3063178</pub-id></mixed-citation></ref><ref id="bib129"><mixed-citation publication-type="journal">Maheshwari RK, Tandon RN, Feuillette AR, Mahouy G, Badillet G, Friedman RM. <article-title>Interferon inhibits <italic>Aspergillus fumigatus</italic> growth in mice: an activity against an extracellular infection</article-title>. <source>J Interferon Res</source>
<year>1988</year>; <volume>8</volume>: <fpage>35</fpage>&#x02013;44.<pub-id pub-id-type="pmid">2452848</pub-id></mixed-citation></ref><ref id="bib130"><mixed-citation publication-type="journal">Inglis DO, Berkes CA, Hocking Murray DR, Sil A. <article-title>Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages</article-title>. <source>Infect Immun</source>
<year>2010</year>; <volume>78</volume>: <fpage>3871</fpage>&#x02013;3882.<pub-id pub-id-type="pmid">20605974</pub-id></mixed-citation></ref><ref id="bib131"><mixed-citation publication-type="journal">Bourgeois C, Majer O, Frohner IE, Lesiak-Markowicz I, Hildering KS, Glaser W et al. <article-title>Conventional dendritic cells mount a type I IFN response against <italic>Candida</italic> spp. requiring novel phagosomal TLR7-mediated IFN-beta signaling</article-title>. <source>J Immunol</source>
<year>2011</year>; <volume>186</volume>: <fpage>3104</fpage>&#x02013;3112.<pub-id pub-id-type="pmid">21282509</pub-id></mixed-citation></ref><ref id="bib132"><mixed-citation publication-type="journal">Lippmann J, Muller HC, Naujoks J, Tabeling C, Shin S, Witzenrath M et al. <article-title>Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice</article-title>. <source>Cell Microbiol</source>
<year>2011</year>; <volume>13</volume>: <fpage>1668</fpage>&#x02013;1682.<pub-id pub-id-type="pmid">21790939</pub-id></mixed-citation></ref><ref id="bib133"><mixed-citation publication-type="journal">de la Maza LM, Peterson EM, Goebel JM, Fennie CW, Czarniecki CW. <article-title>Interferon-induced inhibition of <italic>Chlamydia trachomatis</italic>: dissociation from antiviral and antiproliferative effects</article-title>. <source>Infect Immun</source>
<year>1985</year>; <volume>47</volume>: <fpage>719</fpage>&#x02013;722.<pub-id pub-id-type="pmid">3972450</pub-id></mixed-citation></ref><ref id="bib134"><mixed-citation publication-type="journal">Kazar J, Gillmore JD, Gordon FB. <article-title>Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, <italic>Chlamydia trachomatis</italic></article-title>. <source>Infect Immun</source>
<year>1971</year>; <volume>3</volume>: <fpage>825</fpage>&#x02013;832.<pub-id pub-id-type="pmid">16558062</pub-id></mixed-citation></ref><ref id="bib135"><mixed-citation publication-type="journal">Walberg K, Baron S, Poast J, Schwartz B, Izotova L, Pestka S et al. <article-title>Interferon protects mice against inhalation anthrax</article-title>. <source>J Interferon Cytokine Res</source>
<year>2008</year>; <volume>28</volume>: <fpage>597</fpage>&#x02013;601.<pub-id pub-id-type="pmid">18778201</pub-id></mixed-citation></ref><ref id="bib136"><mixed-citation publication-type="journal">Freudenberg MA, Merlin T, Kalis C, Chvatchko Y, Stubig H, Galanos C. <article-title>Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling</article-title>. <source>J Immunol</source>
<year>2002</year>; <volume>169</volume>: <fpage>1665</fpage>&#x02013;1668.<pub-id pub-id-type="pmid">12165484</pub-id></mixed-citation></ref><ref id="bib137"><mixed-citation publication-type="journal">Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, Murray PJ et al. <article-title>Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title>. <source>J Interferon Cytokine Res</source>
<year>2005</year>; <volume>25</volume>: <fpage>694</fpage>&#x02013;701.<pub-id pub-id-type="pmid">16318583</pub-id></mixed-citation></ref><ref id="bib138"><mixed-citation publication-type="journal">Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM et al. <article-title>Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2001</year>; <volume>98</volume>: <fpage>5752</fpage>&#x02013;5757.<pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="bib139"><mixed-citation publication-type="journal">Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, Shanley C et al. <article-title>The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation</article-title>. <source>J Immunol</source>
<year>2007</year>; <volume>179</volume>: <fpage>522</fpage>&#x02013;531.<pub-id pub-id-type="pmid">17579073</pub-id></mixed-citation></ref><ref id="bib140"><mixed-citation publication-type="journal">Stanley SA, Johndrow JE, Manzanillo P, Cox JS. <article-title>The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis</article-title>. <source>J Immunol</source>
<year>2007</year>; <volume>178</volume>: <fpage>3143</fpage>&#x02013;3152.<pub-id pub-id-type="pmid">17312162</pub-id></mixed-citation></ref><ref id="bib141"><mixed-citation publication-type="journal">Antonelli LR, Gigliotti Rothfuchs A, Goncalves R, Roffe E, Cheever AW, Bafica A et al. <article-title>Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population</article-title>. <source>J Clin Invest</source>
<year>2010</year>; <volume>120</volume>: <fpage>1674</fpage>&#x02013;1682.<pub-id pub-id-type="pmid">20389020</pub-id></mixed-citation></ref><ref id="bib142"><mixed-citation publication-type="journal">Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T et al. <article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source>
<year>2010</year>; <volume>466</volume>: <fpage>973</fpage>&#x02013;977.<pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="bib143"><mixed-citation publication-type="journal">Redford PS, Mayer-Barber KD, McNab FW, Stavropoulos E, Wack A, Sher A et al. <article-title>Influenza A virus impairs control of <italic>Mycobacterium tuberculosis</italic> coinfection through a type I interferon receptor-dependent pathway</article-title>. <source>J Infect Dis</source>
<year>2014</year>; <volume>209</volume>: <fpage>270</fpage>&#x02013;274.<pub-id pub-id-type="pmid">23935205</pub-id></mixed-citation></ref><ref id="bib144"><mixed-citation publication-type="journal">O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B et al. <article-title>Type I interferon production enhances susceptibility to <italic>Listeria monocytogenes</italic> infection</article-title>. <source>J Exp Med</source>
<year>2004</year>; <volume>200</volume>: <fpage>437</fpage>&#x02013;445.<pub-id pub-id-type="pmid">15302901</pub-id></mixed-citation></ref><ref id="bib145"><mixed-citation publication-type="journal">Carrero JA, Calderon B, Unanue ER. <article-title>Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection</article-title>. <source>J Exp Med</source>
<year>2004</year>; <volume>200</volume>: <fpage>535</fpage>&#x02013;540.<pub-id pub-id-type="pmid">15302900</pub-id></mixed-citation></ref><ref id="bib146"><mixed-citation publication-type="journal">Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. <article-title>Mice lacking the type I interferon receptor are resistant to <italic>Listeria monocytogenes</italic></article-title>. <source>J Exp Med</source>
<year>2004</year>; <volume>200</volume>: <fpage>527</fpage>&#x02013;533.<pub-id pub-id-type="pmid">15302899</pub-id></mixed-citation></ref><ref id="bib147"><mixed-citation publication-type="journal">Martin FJ, Gomez MI, Wetzel DM, Memmi G, O'Seaghdha M, Soong G et al. <article-title><italic>Staphylococcus aureus</italic> activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A</article-title>. <source>J Clin Invest</source>
<year>2009</year>; <volume>119</volume>: <fpage>1931</fpage>&#x02013;1939.<pub-id pub-id-type="pmid">19603548</pub-id></mixed-citation></ref><ref id="bib148"><mixed-citation publication-type="journal">Merches K, Khairnar V, Knuschke T, Shaabani N, Honke N, Duhan V et al. <article-title>Virus-induced type I interferon deteriorates control of systemic <italic>Pseudomonas aeruginosa</italic> infection</article-title>. <source>Cell Physiol Biochem</source>
<year>2015</year>; <volume>36</volume>: <fpage>2379</fpage>&#x02013;2392.<pub-id pub-id-type="pmid">26279441</pub-id></mixed-citation></ref><ref id="bib149"><mixed-citation publication-type="journal">Henderson C, Goldbach-Mansky R. <article-title>Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis</article-title>. <source>Curr Opin Rheumatol</source>
<year>2010</year>; <volume>22</volume>: <fpage>567</fpage>&#x02013;578.<pub-id pub-id-type="pmid">20671522</pub-id></mixed-citation></ref><ref id="bib150"><mixed-citation publication-type="journal">Crow YJ, Manel N. <article-title>Aicardi-Goutieres syndrome and the type I interferonopathies</article-title>. <source>Nat Rev Immunol</source>
<year>2015</year>; <volume>15</volume>: <fpage>429</fpage>&#x02013;440.<pub-id pub-id-type="pmid">26052098</pub-id></mixed-citation></ref><ref id="bib151"><mixed-citation publication-type="journal">Huang Y, Blatt LM, Taylor MW. <article-title>Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist</article-title>. <source>J Interferon Cytokine Res</source>
<year>1995</year>; <volume>15</volume>: <fpage>317</fpage>&#x02013;321.<pub-id pub-id-type="pmid">7627806</pub-id></mixed-citation></ref><ref id="bib152"><mixed-citation publication-type="journal">Tilg H, Mier JW, Vogel W, Aulitzky WE, Wiedermann CJ, Vannier E et al. <article-title>Induction of circulating IL-1 receptor antagonist by IFN treatment</article-title>. <source>J Immunol</source>
<year>1993</year>; <volume>150</volume>: <fpage>4687</fpage>&#x02013;4692.<pub-id pub-id-type="pmid">8482853</pub-id></mixed-citation></ref><ref id="bib153"><mixed-citation publication-type="journal">Coclet-Ninin J, Dayer JM, Burger D. <article-title>Interferon-beta not only inhibits interleukin-1beta and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells</article-title>. <source>Eur Cytokine Netw</source>
<year>1997</year>; <volume>8</volume>: <fpage>345</fpage>&#x02013;349.<pub-id pub-id-type="pmid">9459613</pub-id></mixed-citation></ref><ref id="bib154"><mixed-citation publication-type="journal">Reznikov LL, Puren AJ, Fantuzzi G, Muhl H, Shapiro L, Yoon DY et al. <article-title>Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8</article-title>. <source>J Interferon Cytokine Res</source>
<year>1998</year>; <volume>18</volume>: <fpage>897</fpage>&#x02013;903.<pub-id pub-id-type="pmid">9809626</pub-id></mixed-citation></ref><ref id="bib155"><mixed-citation publication-type="journal">Billiau A. <article-title>Anti-inflammatory properties of type I interferons</article-title>. <source>Antiviral Res</source>
<year>2006</year>; <volume>71</volume>: <fpage>108</fpage>&#x02013;116.<pub-id pub-id-type="pmid">16626815</pub-id></mixed-citation></ref><ref id="bib156"><mixed-citation publication-type="journal">Radwan M, Stiefvater R, Grunert T, Sharif O, Miller I, Marchetti-Deschmann M et al. <article-title>Tyrosine kinase 2 controls IL-1ss production at the translational level</article-title>. <source>J Immunol</source>
<year>2010</year>; <volume>185</volume>: <fpage>3544</fpage>&#x02013;3553.<pub-id pub-id-type="pmid">20713887</pub-id></mixed-citation></ref><ref id="bib157"><mixed-citation publication-type="journal">Castiglia V, Piersigilli A, Ebner F, Janos M, Goldmann O, Dambock U et al. <article-title>Type I interferon signaling prevents IL-1beta-driven lethal systemic hyperinflammation during invasive bacterial infection of soft tissue</article-title>. <source>Cell Host Microbe</source>
<year>2016</year>; <volume>19</volume>: <fpage>375</fpage>&#x02013;387.<pub-id pub-id-type="pmid">26962946</pub-id></mixed-citation></ref><ref id="bib158"><mixed-citation publication-type="journal">Henry T, Kirimanjeswara GS, Ruby T, Jones JW, Peng K, Perret M et al. <article-title>Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections</article-title>. <source>J Immunol</source>
<year>2010</year>; <volume>184</volume>: <fpage>3755</fpage>&#x02013;3767.<pub-id pub-id-type="pmid">20176744</pub-id></mixed-citation></ref><ref id="bib159"><mixed-citation publication-type="journal">Perkins DJ, Rajaiah R, Tennant SM, Ramachandran G, Higginson EE, Dyson TN et al. <article-title><italic>Salmonella typhimurium</italic> co-opts the host type I IFN system to restrict macrophage innate immune transcriptional responses selectively</article-title>. <source>J Immunol</source>
<year>2015</year>; <volume>195</volume>: <fpage>2461</fpage>&#x02013;2471.<pub-id pub-id-type="pmid">26202980</pub-id></mixed-citation></ref><ref id="bib160"><mixed-citation publication-type="journal">de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. <article-title>Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes</article-title>. <source>J Exp Med</source>
<year>1991</year>; <volume>174</volume>: <fpage>1209</fpage>&#x02013;1220.<pub-id pub-id-type="pmid">1940799</pub-id></mixed-citation></ref><ref id="bib161"><mixed-citation publication-type="journal">Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C. <article-title>Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist</article-title>. <source>Blood</source>
<year>1994</year>; <volume>84</volume>: <fpage>4142</fpage>&#x02013;4150.<pub-id pub-id-type="pmid">7994029</pub-id></mixed-citation></ref><ref id="bib162"><mixed-citation publication-type="journal">Naveau S, Emilie D, Borotto E, Portier A, Lazizi Y, Giraud V et al. <article-title>Interleukin-1 receptor antagonist plasma concentration is specifically increased by alpha-2A-interferon treatment</article-title>. <source>J Hepatol</source>
<year>1997</year>; <volume>27</volume>: <fpage>272</fpage>&#x02013;275.<pub-id pub-id-type="pmid">9288600</pub-id></mixed-citation></ref><ref id="bib163"><mixed-citation publication-type="journal">Danis VA, Kulesz AJ, Nelson DS, Brooks PM. <article-title>Cytokine regulation of human monocyte interleukin-1 (IL-1) production <italic>in vitro</italic>. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha</article-title>. <source>Clin Exp Immunol</source>
<year>1990</year>; <volume>80</volume>: <fpage>435</fpage>&#x02013;443.<pub-id pub-id-type="pmid">2115419</pub-id></mixed-citation></ref><ref id="bib164"><mixed-citation publication-type="journal">Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I et al. <article-title>Type I interferon inhibits interleukin-1 production and inflammasome activation</article-title>. <source>Immunity</source>
<year>2011</year>; <volume>34</volume>: <fpage>213</fpage>&#x02013;223.<pub-id pub-id-type="pmid">21349431</pub-id></mixed-citation></ref><ref id="bib165"><mixed-citation publication-type="journal">Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. <article-title>IL-10 inhibits cytokine production by activated macrophages</article-title>. <source>J Immunol</source>
<year>1991</year>; <volume>147</volume>: <fpage>3815</fpage>&#x02013;3822.<pub-id pub-id-type="pmid">1940369</pub-id></mixed-citation></ref><ref id="bib166"><mixed-citation publication-type="journal">Reboldi A, Dang EV, McDonald JG, Liang G, Russell DW, Cyster JG. <article-title>Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon</article-title>. <source>Science</source>
<year>2014</year>; <volume>345</volume>: <fpage>679</fpage>&#x02013;684.<pub-id pub-id-type="pmid">25104388</pub-id></mixed-citation></ref><ref id="bib167"><mixed-citation publication-type="journal">Schindler R, Ghezzi P, Dinarello CA. <article-title>IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1</article-title>. <source>J Immunol</source>
<year>1990</year>; <volume>144</volume>: <fpage>2216</fpage>&#x02013;2222.<pub-id pub-id-type="pmid">2107255</pub-id></mixed-citation></ref><ref id="bib168"><mixed-citation publication-type="journal">Hara K, Shirasuna K, Usui F, Karasawa T, Mizushina Y, Kimura H et al. <article-title>Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1beta in macrophages</article-title>. <source>PLoS One</source>
<year>2014</year>; <volume>9</volume>: <fpage>e113974</fpage>.<pub-id pub-id-type="pmid">25486008</pub-id></mixed-citation></ref><ref id="bib169"><mixed-citation publication-type="journal">Blazek K, Eames HL, Weiss M, Byrne AJ, Perocheau D, Pease JE et al. <article-title>IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production</article-title>. <source>J Exp Med</source>
<year>2015</year>; <volume>212</volume>: <fpage>845</fpage>&#x02013;853.<pub-id pub-id-type="pmid">25941255</pub-id></mixed-citation></ref><ref id="bib170"><mixed-citation publication-type="journal">Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L et al. <article-title>The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses</article-title>. <source>Nat Immunol</source>
<year>2010</year>; <volume>11</volume>: <fpage>395</fpage>&#x02013;402.<pub-id pub-id-type="pmid">20351692</pub-id></mixed-citation></ref><ref id="bib171"><mixed-citation publication-type="journal">Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J et al. <article-title>The AIM2 inflammasome is critical for innate immunity to <italic>Francisella tularensis</italic></article-title>. <source>Nat Immunol</source>
<year>2010</year>; <volume>11</volume>: <fpage>385</fpage>&#x02013;393.<pub-id pub-id-type="pmid">20351693</pub-id></mixed-citation></ref><ref id="bib172"><mixed-citation publication-type="journal">Sauer JD, Witte CE, Zemansky J, Hanson B, Lauer P, Portnoy DA. <article-title>Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol</article-title>. <source>Cell Host Microbe</source>
<year>2010</year>; <volume>7</volume>: <fpage>412</fpage>&#x02013;419.<pub-id pub-id-type="pmid">20417169</pub-id></mixed-citation></ref><ref id="bib173"><mixed-citation publication-type="journal">Jones JW, Kayagaki N, Broz P, Henry T, Newton K, O'Rourke K et al. <article-title>Absent in melanoma 2 is required for innate immune recognition of <italic>Francisella tularensis</italic></article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2010</year>; <volume>107</volume>: <fpage>9771</fpage>&#x02013;9776.<pub-id pub-id-type="pmid">20457908</pub-id></mixed-citation></ref><ref id="bib174"><mixed-citation publication-type="journal">Tian Z, Shen X, Feng H, Gao B. <article-title>IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway</article-title>. <source>J Immunol</source>
<year>2000</year>; <volume>165</volume>: <fpage>3959</fpage>&#x02013;3965.<pub-id pub-id-type="pmid">11034404</pub-id></mixed-citation></ref><ref id="bib175"><mixed-citation publication-type="journal">Kohase M, Zhang YH, Lin JX, Yamazaki S, Sehgal PB, Vilcek J. <article-title>Interleukin-1 can inhibit interferon-beta synthesis and its antiviral action: comparison with tumor necrosis factor</article-title>. <source>J Interferon Res</source>
<year>1988</year>; <volume>8</volume>: <fpage>559</fpage>&#x02013;570.<pub-id pub-id-type="pmid">3262700</pub-id></mixed-citation></ref><ref id="bib176"><mixed-citation publication-type="journal">Coulombe F, Jaworska J, Verway M, Tzelepis F, Massoud A, Gillard J et al. <article-title>Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages</article-title>. <source>Immunity</source>
<year>2014</year>; <volume>40</volume>: <fpage>554</fpage>&#x02013;568.<pub-id pub-id-type="pmid">24726877</pub-id></mixed-citation></ref><ref id="bib177"><mixed-citation publication-type="journal">Xu XJ, Reichner JS, Mastrofrancesco B, Henry WL Jr, Albina JE. <article-title>Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production</article-title>. <source>J Immunol</source>
<year>2008</year>; <volume>180</volume>: <fpage>2125</fpage>&#x02013;2131.<pub-id pub-id-type="pmid">18250418</pub-id></mixed-citation></ref><ref id="bib178"><mixed-citation publication-type="journal">McNab FW, Ewbank J, Howes A, Moreira-Teixeira L, Martirosyan A, Ghilardi N et al. <article-title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-gamma for production of IL-12 and bacterial killing in <italic>Mycobacterium tuberculosis</italic>-infected macrophages</article-title>. <source>J Immunol</source>
<year>2014</year>; <volume>193</volume>: <fpage>3600</fpage>&#x02013;3612.<pub-id pub-id-type="pmid">25187652</pub-id></mixed-citation></ref><ref id="bib179"><mixed-citation publication-type="journal">Koo IC, Wang C, Raghavan S, Morisaki JH, Cox JS, Brown EJ. <article-title>ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection</article-title>. <source>Cell Microbiol</source>
<year>2008</year>; <volume>10</volume>: <fpage>1866</fpage>&#x02013;1878.<pub-id pub-id-type="pmid">18503637</pub-id></mixed-citation></ref><ref id="bib180"><mixed-citation publication-type="journal">Wassermann R, Gulen MF, Sala C, Perin SG, Lou Y, Rybniker J et al. <article-title><italic>Mycobacterium tuberculosis</italic> differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1</article-title>. <source>Cell Host Microbe</source>
<year>2015</year>; <volume>17</volume>: <fpage>799</fpage>&#x02013;810.<pub-id pub-id-type="pmid">26048138</pub-id></mixed-citation></ref><ref id="bib181"><mixed-citation publication-type="journal">Watson RO, Bell SL, MacDuff DA, Kimmey JM, Diner EJ, Olivas J et al. <article-title>The cytosolic sensor cGAS detects <italic>Mycobacterium tuberculosis</italic> DNA to induce type I interferons and activate autophagy</article-title>. <source>Cell Host Microbe</source>
<year>2015</year>; <volume>17</volume>: <fpage>811</fpage>&#x02013;819.<pub-id pub-id-type="pmid">26048136</pub-id></mixed-citation></ref><ref id="bib182"><mixed-citation publication-type="journal">Collins AC, Cai H, Li T, Franco LH, Li XD, Nair VR et al. <article-title>Cyclic GMP-AMP synthase is an innate immune DNA sensor for <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Cell Host Microbe</source>
<year>2015</year>; <volume>17</volume>: <fpage>820</fpage>&#x02013;828.<pub-id pub-id-type="pmid">26048137</pub-id></mixed-citation></ref><ref id="bib183"><mixed-citation publication-type="journal">Dey B, Dey RJ, Cheung LS, Pokkali S, Guo H, Lee JH et al. <article-title>A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis</article-title>. <source>Nat Med</source>
<year>2015</year>; <volume>21</volume>: <fpage>401</fpage>&#x02013;406.<pub-id pub-id-type="pmid">25730264</pub-id></mixed-citation></ref><ref id="bib184"><mixed-citation publication-type="journal">Snell LM, Brooks DG. <article-title>New insights into type I interferon and the immunopathogenesis of persistent viral infections</article-title>. <source>Curr Opin Immunol</source>
<year>2015</year>; <volume>34</volume>: <fpage>91</fpage>&#x02013;98.<pub-id pub-id-type="pmid">25771184</pub-id></mixed-citation></ref><ref id="bib185"><mixed-citation publication-type="journal">Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G et al. <article-title>Blockade of chronic type I interferon signaling to control persistent LCMV infection</article-title>. <source>Science</source>
<year>2013</year>; <volume>340</volume>: <fpage>202</fpage>&#x02013;207.<pub-id pub-id-type="pmid">23580528</pub-id></mixed-citation></ref><ref id="bib186"><mixed-citation publication-type="journal">Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M et al. <article-title>Persistent LCMV infection is controlled by blockade of type I interferon signaling</article-title>. <source>Science</source>
<year>2013</year>; <volume>340</volume>: <fpage>207</fpage>&#x02013;211.<pub-id pub-id-type="pmid">23580529</pub-id></mixed-citation></ref><ref id="bib187"><mixed-citation publication-type="journal">Ng CT, Sullivan BM, Teijaro JR, Lee AM, Welch M, Rice S et al. <article-title>Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection</article-title>. <source>Cell Host Microbe</source>
<year>2015</year>; <volume>17</volume>: <fpage>653</fpage>&#x02013;661.<pub-id pub-id-type="pmid">25974304</pub-id></mixed-citation></ref><ref id="bib188"><mixed-citation publication-type="journal">Tanabe M, Matsumoto T, Shibuya K, Tateda K, Miyazaki S, Nakane A et al. <article-title>Compensatory response of IL-1 gene knockout mice after pulmonary infection with <italic>Klebsiella pneumoniae</italic></article-title>. <source>J Med Microbiol</source>
<year>2005</year>; <volume>54</volume>: <fpage>7</fpage>&#x02013;13.<pub-id pub-id-type="pmid">15591249</pub-id></mixed-citation></ref><ref id="bib189"><mixed-citation publication-type="journal">Parker D, Planet PJ, Soong G, Narechania A, Prince A. <article-title>Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains</article-title>. <source>PLoS Pathog</source>
<year>2014</year>; <volume>10</volume>: <fpage>e1003951</fpage>.<pub-id pub-id-type="pmid">24586160</pub-id></mixed-citation></ref><ref id="bib190"><mixed-citation publication-type="journal">Kafka D, Ling E, Feldman G, Benharroch D, Voronov E, Givon-Lavi N et al. <article-title>Contribution of IL-1 to resistance to Streptococcus pneumoniae infection</article-title>. <source>Int Immunol</source>
<year>2008</year>; <volume>20</volume>: <fpage>1139</fpage>&#x02013;1146.<pub-id pub-id-type="pmid">18596024</pub-id></mixed-citation></ref><ref id="bib191"><mixed-citation publication-type="journal">Biondo C, Mancuso G, Midiri A, Signorino G, Domina M, Lanza Cariccio V et al. <article-title>Essential role of interleukin-1 signaling in host defenses against group B streptococcus</article-title>. <source>MBio</source>
<year>2014</year>; <volume>5</volume>: <fpage>e01428</fpage>&#x02013;01414.<pub-id pub-id-type="pmid">25205091</pub-id></mixed-citation></ref><ref id="bib192"><mixed-citation publication-type="journal">Zwijnenburg PJ, van der Poll T, Florquin S, Roord JJ, Van Furth AM. <article-title>IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis</article-title>. <source>J Immunol</source>
<year>2003</year>; <volume>170</volume>: <fpage>4724</fpage>&#x02013;4730.<pub-id pub-id-type="pmid">12707352</pub-id></mixed-citation></ref><ref id="bib193"><mixed-citation publication-type="journal">Mancuso G, Midiri A, Biondo C, Beninati C, Zummo S, Galbo R et al. <article-title>Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria</article-title>. <source>J Immunol</source>
<year>2007</year>; <volume>178</volume>: <fpage>3126</fpage>&#x02013;3133.<pub-id pub-id-type="pmid">17312160</pub-id></mixed-citation></ref><ref id="bib194"><mixed-citation publication-type="journal">Gratz N, Hartweger H, Matt U, Kratochvill F, Janos M, Sigel S et al. <article-title>Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection</article-title>. <source>PLoS Pathog</source>
<year>2011</year>; <volume>7</volume>: <fpage>e1001345</fpage>.<pub-id pub-id-type="pmid">21625574</pub-id></mixed-citation></ref><ref id="bib195"><mixed-citation publication-type="journal">Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, Caspar P et al. <article-title>Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals</article-title>. <source>J Immunol</source>
<year>2003</year>; <volume>171</volume>: <fpage>4758</fpage>&#x02013;4764.<pub-id pub-id-type="pmid">14568952</pub-id></mixed-citation></ref><ref id="bib196"><mixed-citation publication-type="journal">Denis M. <article-title>Recombinant murine beta interferon enhances resistance of mice to systemic <italic>Mycobacterium avium</italic> infection</article-title>. <source>Infect Immun</source>
<year>1991</year>; <volume>59</volume>: <fpage>1857</fpage>&#x02013;1859.<pub-id pub-id-type="pmid">2019446</pub-id></mixed-citation></ref><ref id="bib197"><mixed-citation publication-type="journal">Rogers HW, Tripp CS, Schreiber RD, Unanue ER. <article-title>Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis</article-title>. <source>J Immunol</source>
<year>1994</year>; <volume>153</volume>: <fpage>2093</fpage>&#x02013;2101.<pub-id pub-id-type="pmid">8051414</pub-id></mixed-citation></ref><ref id="bib198"><mixed-citation publication-type="journal">Rogers HW, Sheehan KC, Brunt LM, Dower SK, Unanue ER, Schreiber RD. <article-title>Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>1992</year>; <volume>89</volume>: <fpage>1011</fpage>&#x02013;1015.<pub-id pub-id-type="pmid">1531270</pub-id></mixed-citation></ref><ref id="bib199"><mixed-citation publication-type="journal">Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S. <article-title>Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium</article-title>. <source>Nat Immunol</source>
<year>2012</year>; <volume>13</volume>: <fpage>954</fpage>&#x02013;962.<pub-id pub-id-type="pmid">22922364</pub-id></mixed-citation></ref><ref id="bib200"><mixed-citation publication-type="journal">Raupach B, Peuschel SK, Monack DM, Zychlinsky A. <article-title>Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against <italic>Salmonella enterica</italic> serovar Typhimurium infection</article-title>. <source>Infect Immun</source>
<year>2006</year>; <volume>74</volume>: <fpage>4922</fpage>&#x02013;4926.<pub-id pub-id-type="pmid">16861683</pub-id></mixed-citation></ref><ref id="bib201"><mixed-citation publication-type="journal">del Barrio L, Sahoo M, Lantier L, Reynolds JM, Ceballos-Olvera I, Re F. <article-title>Production of anti-LPS IgM by B1a B cells depends on IL-1beta and is protective against lung infection with Francisella tularensis LVS</article-title>. <source>PLoS Pathog</source>
<year>2015</year>; <volume>11</volume>: <fpage>e1004706</fpage>.<pub-id pub-id-type="pmid">25768794</pub-id></mixed-citation></ref><ref id="bib202"><mixed-citation publication-type="journal">Kang TJ, Basu S, Zhang L, Thomas KE, Vogel SN, Baillie L et al. <article-title><italic>Bacillus anthracis</italic> spores and lethal toxin induce IL-1beta via functionally distinct signaling pathways</article-title>. <source>Eur J Immunol</source>
<year>2008</year>; <volume>38</volume>: <fpage>1574</fpage>&#x02013;1584.<pub-id pub-id-type="pmid">18493980</pub-id></mixed-citation></ref><ref id="bib203"><mixed-citation publication-type="journal">Wang JP, Lee CK, Akalin A, Finberg RW, Levitz SM. <article-title>Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with <italic>Cryptococcus neoformans</italic></article-title>. <source>PLoS One</source>
<year>2011</year>; <volume>6</volume>: <fpage>e26232</fpage>.<pub-id pub-id-type="pmid">22039448</pub-id></mixed-citation></ref><ref id="bib204"><mixed-citation publication-type="journal">Bellocchio S, Montagnoli C, Bozza S, Gaziano R, Rossi G, Mambula SS et al. <article-title>The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens <italic>in vivo</italic></article-title>. <source>J Immunol</source>
<year>2004</year>; <volume>172</volume>: <fpage>3059</fpage>&#x02013;3069.<pub-id pub-id-type="pmid">14978111</pub-id></mixed-citation></ref><ref id="bib205"><mixed-citation publication-type="journal">Hung CY, Jimenez-Alzate Mdel P, Gonzalez A, Wuthrich M, Klein BS, Cole GT. <article-title>Interleukin-1 receptor but not Toll-like receptor 2 is essential for MyD88-dependent Th17 immunity to Coccidioides infection</article-title>. <source>Infect Immun</source>
<year>2014</year>; <volume>82</volume>: <fpage>2106</fpage>&#x02013;2114.<pub-id pub-id-type="pmid">24614655</pub-id></mixed-citation></ref><ref id="bib206"><mixed-citation publication-type="journal">Deepe GS Jr, McGuinness M. <article-title>Interleukin-1 and host control of pulmonary histoplasmosis</article-title>. <source>J Infect Dis</source>
<year>2006</year>; <volume>194</volume>: <fpage>855</fpage>&#x02013;864.<pub-id pub-id-type="pmid">16941354</pub-id></mixed-citation></ref><ref id="bib207"><mixed-citation publication-type="journal">Voronov E, Dotan S, Gayvoronsky L, White RM, Cohen I, Krelin Y et al. <article-title>IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice</article-title>. <source>Int Immunol</source>
<year>2010</year>; <volume>22</volume>: <fpage>245</fpage>&#x02013;257.<pub-id pub-id-type="pmid">20181656</pub-id></mixed-citation></ref><ref id="bib208"><mixed-citation publication-type="journal">Kostka SL, Knop J, Konur A, Udey MC, von Stebut E. <article-title>Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections</article-title>. <source>J Invest Dermatol</source>
<year>2006</year>; <volume>126</volume>: <fpage>1582</fpage>&#x02013;1589.<pub-id pub-id-type="pmid">16645594</pub-id></mixed-citation></ref><ref id="bib209"><mixed-citation publication-type="journal">Charmoy M, Hurrell BP, Romano A, Lee SH, Ribeiro-Gomes F, Riteau N et al. <article-title>The Nlrp3 inflammasome, IL-1beta, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice</article-title>. <source>Eur J Immunol</source>
<year>2016</year>; <volume>46</volume>: <fpage>897</fpage>&#x02013;911.<pub-id pub-id-type="pmid">26689285</pub-id></mixed-citation></ref><ref id="bib210"><mixed-citation publication-type="journal">Mattner J, Wandersee-Steinhauser A, Pahl A, Rollinghoff M, Majeau GR, Hochman PS et al. <article-title>Protection against progressive leishmaniasis by IFN-beta</article-title>. <source>J Immunol</source>
<year>2004</year>; <volume>172</volume>: <fpage>7574</fpage>&#x02013;7582.<pub-id pub-id-type="pmid">15187137</pub-id></mixed-citation></ref><ref id="bib211"><mixed-citation publication-type="journal">Mattner J, Schindler H, Diefenbach A, Rollinghoff M, Gresser I, Bogdan C. <article-title>Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major</article-title>. <source>Eur J Immunol</source>
<year>2000</year>; <volume>30</volume>: <fpage>2257</fpage>&#x02013;2267.<pub-id pub-id-type="pmid">10940917</pub-id></mixed-citation></ref><ref id="bib212"><mixed-citation publication-type="journal">Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J et al. <article-title>Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite</article-title>. <source>Immunity</source>
<year>1998</year>; <volume>8</volume>: <fpage>77</fpage>&#x02013;87.<pub-id pub-id-type="pmid">9462513</pub-id></mixed-citation></ref><ref id="bib213"><mixed-citation publication-type="journal">Curfs JH, van der Meer JW, Sauerwein RW, Eling WM. <article-title>Low dosages of interleukin 1 protect mice against lethal cerebral malaria</article-title>. <source>J Exp Med</source>
<year>1990</year>; <volume>172</volume>: <fpage>1287</fpage>&#x02013;1291.<pub-id pub-id-type="pmid">2230643</pub-id></mixed-citation></ref><ref id="bib214"><mixed-citation publication-type="journal">Voisine C, Mastelic B, Sponaas AM, Langhorne J. <article-title>Classical CD11c&#x0002b; dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to <italic>Plasmodium chabaudi</italic> malaria</article-title>. <source>Int J Parasitol</source>
<year>2010</year>; <volume>40</volume>: <fpage>711</fpage>&#x02013;719.<pub-id pub-id-type="pmid">19968996</pub-id></mixed-citation></ref><ref id="bib215"><mixed-citation publication-type="journal">Vigario AM, Belnoue E, Gruner AC, Mauduit M, Kayibanda M, Deschemin JC et al. <article-title>Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice</article-title>. <source>J Immunol</source>
<year>2007</year>; <volume>178</volume>: <fpage>6416</fpage>&#x02013;6425.<pub-id pub-id-type="pmid">17475871</pub-id></mixed-citation></ref><ref id="bib216"><mixed-citation publication-type="journal">Vigario AM, Belnoue E, Cumano A, Marussig M, Miltgen F, Landau I et al. <article-title>Inhibition of <italic>Plasmodium yoelii</italic> blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte</article-title>. <source>Blood</source>
<year>2001</year>; <volume>97</volume>: <fpage>3966</fpage>&#x02013;3971.<pub-id pub-id-type="pmid">11389041</pub-id></mixed-citation></ref><ref id="bib217"><mixed-citation publication-type="journal">Liehl P, Zuzarte-Luis V, Chan J, Zillinger T, Baptista F, Carapau D et al. <article-title>Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection</article-title>. <source>Nat Med</source>
<year>2014</year>; <volume>20</volume>: <fpage>47</fpage>&#x02013;53.<pub-id pub-id-type="pmid">24362933</pub-id></mixed-citation></ref><ref id="bib218"><mixed-citation publication-type="journal">Haque A, Best SE, Ammerdorffer A, Desbarrieres L, de Oca MM, Amante FH et al. <article-title>Type I interferons suppress CD4(&#x0002b;) T-cell-dependent parasite control during blood-stage Plasmodium infection</article-title>. <source>Eur J Immunol</source>
<year>2011</year>; <volume>41</volume>: <fpage>2688</fpage>&#x02013;2698.<pub-id pub-id-type="pmid">21674481</pub-id></mixed-citation></ref><ref id="bib219"><mixed-citation publication-type="journal">Lopez R, Demick KP, Mansfield JM, Paulnock DM. <article-title>Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes</article-title>. <source>J Immunol</source>
<year>2008</year>; <volume>181</volume>: <fpage>4908</fpage>&#x02013;4917.<pub-id pub-id-type="pmid">18802094</pub-id></mixed-citation></ref><ref id="bib220"><mixed-citation publication-type="journal">Koga R, Hamano S, Kuwata H, Atarashi K, Ogawa M, Hisaeda H et al. <article-title>TLR-dependent induction of IFN-beta mediates host defense against <italic>Trypanosoma cruzi</italic></article-title>. <source>J Immunol</source>
<year>2006</year>; <volume>177</volume>: <fpage>7059</fpage>&#x02013;7066.<pub-id pub-id-type="pmid">17082622</pub-id></mixed-citation></ref><ref id="bib221"><mixed-citation publication-type="journal">Costa VM, Torres KC, Mendonca RZ, Gresser I, Gollob KJ, Abrahamsohn IA et al. <article-title>IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection</article-title>. <source>J Immunol</source>
<year>2006</year>; <volume>177</volume>: <fpage>3193</fpage>&#x02013;3200.<pub-id pub-id-type="pmid">16920958</pub-id></mixed-citation></ref><ref id="bib222"><mixed-citation publication-type="journal">Chessler AD, Caradonna KL, Da'dara A, Burleigh BA. <article-title>Type I interferons increase host susceptibility to Trypanosoma cruzi infection</article-title>. <source>Infect Immun</source>
<year>2011</year>; <volume>79</volume>: <fpage>2112</fpage>&#x02013;2119.<pub-id pub-id-type="pmid">21402764</pub-id></mixed-citation></ref><ref id="bib223"><mixed-citation publication-type="journal">Shim YR, Lee HK. <article-title>Caspase-1 independent viral clearance and adaptive immunity against mucosal respiratory syncytial virus infection</article-title>. <source>Immune Netw</source>
<year>2015</year>; <volume>15</volume>: <fpage>73</fpage>&#x02013;82.<pub-id pub-id-type="pmid">25922596</pub-id></mixed-citation></ref><ref id="bib224"><mixed-citation publication-type="journal">Goritzka M, Makris S, Kausar F, Durant LR, Pereira C, Kumagai Y et al. <article-title>Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes</article-title>. <source>J Exp Med</source>
<year>2015</year>; <volume>212</volume>: <fpage>699</fpage>&#x02013;714.<pub-id pub-id-type="pmid">25897172</pub-id></mixed-citation></ref><ref id="bib225"><mixed-citation publication-type="journal">Kamperschroer C, Quinn DG. <article-title>The role of proinflammatory cytokines in wasting disease during lymphocytic choriomeningitis virus infection</article-title>. <source>J Immunol</source>
<year>2002</year>; <volume>169</volume>: <fpage>340</fpage>&#x02013;349.<pub-id pub-id-type="pmid">12077263</pub-id></mixed-citation></ref><ref id="bib226"><mixed-citation publication-type="journal">Joeckel LT, Wallich R, Metkar SS, Froelich CJ, Simon MM, Borner C. <article-title>Interleukin-1R signaling is essential for induction of proapoptotic CD8 T cells, viral clearance, and pathology during lymphocytic choriomeningitis virus infection in mice</article-title>. <source>J Virol</source>
<year>2012</year>; <volume>86</volume>: <fpage>8713</fpage>&#x02013;8719.<pub-id pub-id-type="pmid">22674984</pub-id></mixed-citation></ref><ref id="bib227"><mixed-citation publication-type="journal">Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K et al. <article-title>Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses</article-title>. <source>PLoS Pathog</source>
<year>2008</year>; <volume>4</volume>: <fpage>e1000151</fpage>.<pub-id pub-id-type="pmid">18787692</pub-id></mixed-citation></ref><ref id="bib228"><mixed-citation publication-type="journal">Crotta S, Davidson S, Mahlakoiv T, Desmet CJ, Buckwalter MR, Albert ML et al. <article-title>Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia</article-title>. <source>PLoS Pathog</source>
<year>2013</year>; <volume>9</volume>: <fpage>e1003773</fpage>.<pub-id pub-id-type="pmid">24278020</pub-id></mixed-citation></ref><ref id="bib229"><mixed-citation publication-type="journal">Tanaka J, Ozaki H, Yasuda J, Horai R, Tagawa Y, Asano M et al. <article-title>Lipopolysaccharide-induced HIV-1 expression in transgenic mice is mediated by tumor necrosis factor-alpha and interleukin-1, but not by interferon-gamma nor interleukin-6</article-title>. <source>AIDS</source>
<year>2000</year>; <volume>14</volume>: <fpage>1299</fpage>&#x02013;1307.<pub-id pub-id-type="pmid">10930143</pub-id></mixed-citation></ref><ref id="bib230"><mixed-citation publication-type="journal">He H, Sharer LR, Chao W, Gu CJ, Borjabad A, Hadas E et al. <article-title>Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses</article-title>. <source>J Neuropathol Exp Neurol</source>
<year>2014</year>; <volume>73</volume>: <fpage>59</fpage>&#x02013;71.<pub-id pub-id-type="pmid">24335529</pub-id></mixed-citation></ref><ref id="bib231"><mixed-citation publication-type="journal">Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Stevens S et al. <article-title>Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis</article-title>. <source>Ann Rheum Dis</source>
<year>2009</year>; <volume>68</volume>: <fpage>1602</fpage>&#x02013;1608.<pub-id pub-id-type="pmid">19528034</pub-id></mixed-citation></ref><ref id="bib232"><mixed-citation publication-type="journal">Guo B, Chang EY, Cheng G. <article-title>The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice</article-title>. <source>J Clin Invest</source>
<year>2008</year>; <volume>118</volume>: <fpage>1680</fpage>&#x02013;1690.<pub-id pub-id-type="pmid">18382764</pub-id></mixed-citation></ref><ref id="bib233"><mixed-citation publication-type="journal">Teige I, Treschow A, Teige A, Mattsson R, Navikas V, Leanderson T et al. <article-title>IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis</article-title>. <source>J Immunol</source>
<year>2003</year>; <volume>170</volume>: <fpage>4776</fpage>&#x02013;4784.<pub-id pub-id-type="pmid">12707359</pub-id></mixed-citation></ref><ref id="bib234"><mixed-citation publication-type="journal">Lauwerys BR, Ducreux J, Houssiau FA. <article-title>Type I interferon blockade in systemic lupus erythematosus: where do we stand</article-title>? <source>Rheumatology (Oxford)</source>
<year>2014</year>; <volume>53</volume>: <fpage>1369</fpage>&#x02013;1376.<pub-id pub-id-type="pmid">24344319</pub-id></mixed-citation></ref><ref id="bib235"><mixed-citation publication-type="journal">Crow MK. <article-title>Advances in understanding the role of type I interferons in systemic lupus erythematosus</article-title>. <source>Curr Opin Rheumatol</source>
<year>2014</year>; <volume>26</volume>: <fpage>467</fpage>&#x02013;474.<pub-id pub-id-type="pmid">25010440</pub-id></mixed-citation></ref><ref id="bib236"><mixed-citation publication-type="journal">Amezcua-Guerra LM, Ferrusquia-Toriz D, Castillo-Martinez D, Marquez-Velasco R, Chavez-Rueda AK, Bojalil R. <article-title>Limited effectiveness for the therapeutic blockade of interferon alpha in systemic lupus erythematosus: a possible role for type III interferons</article-title>. <source>Rheumatology (Oxford)</source>
<year>2015</year>; <volume>54</volume>: <fpage>203</fpage>&#x02013;205.<pub-id pub-id-type="pmid">24625504</pub-id></mixed-citation></ref><ref id="bib237"><mixed-citation publication-type="journal">Nacionales DC, Kelly-Scumpia KM, Lee PY, Weinstein JS, Lyons R, Sobel E et al. <article-title>Deficiency of the type I interferon receptor protects mice from experimental lupus</article-title>. <source>Arthritis Rheum</source>
<year>2007</year>; <volume>56</volume>: <fpage>3770</fpage>&#x02013;3783.<pub-id pub-id-type="pmid">17968932</pub-id></mixed-citation></ref></